- ►vcu.edu [PDF] DM Herrington, DM Reboussin, KB Brosnihan, … - New England Journal of Medicine, 2000 - content.nejm.org Results Estrogen and estrogen plus medroxyprogesterone acetate produced
significant reductions in low-density lipoprotein cholesterol levels (9.4
percent and 16.5 percent, respectively) and significant increases in high- ... Cited by 1182 - Related articles - BL Direct - All 12 versions
E Barrett-Connor, D Grady, A Sashegyi, PW … - Jama, 2002 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Raloxifene, a ... Cited by 432 - Related articles - BL Direct - All 8 versions
- ►annals.org [PDF] F Grodstein, JAE Manson, MJ Stampfer - Annals of Internal Medicine, 2001 - Am Coll Physicians Background: The Heart and Estrogen/progestin Replacement Study (HERS) was the
first randomized clinical trial of combined hormone therapy and secondary
prevention of coronary events. The trial had overall null results but ... Cited by 312 - Related articles - All 8 versions
- ►ahajournals.org JF Reckelhoff - Hypertension, 2001 - Am Heart Assoc Abstract—Men are at greater risk for cardiovascular and renal disease than are
age-matched, premenopausal women. Recent studies using the technique of 24-hour
ambulatory blood pressure monitoring have shown that blood pressure is ... Cited by 291 - Related articles - BL Direct - All 11 versions
- ►ahajournals.org P Angerer, S Stork, W Kothny, P Schmitt, C … - Arteriosclerosis, thrombosis, and vascular biology, 2001 - Am Heart Assoc Abstract—Postmenopausal hormone replacement therapy (HRT) is associated with
low cardiovascular morbidity and mortality in epidemiological studies. Yet, no
randomized trial has examined whether HRT is effective for prevention of ... Cited by 224 - Related articles - BL Direct - All 8 versions
- ►unc.edu [PDF] SR Heckbert, RC Kaplan, NS Weiss, BM Psaty, … - Archives of Internal Medicine, 2001 - Am Med Assoc Background The finding from the Heart and Estrogen/Progestin Replacement Study
(HERS) of increased coronary risk restricted to the first year after starting
postmenopausal hormone therapy raises new questions about the role of ... Cited by 77 - Related articles - BL Direct - All 6 versions
JF Reckelhoff - Hypertension, 2005 - Am Heart Assoc The roles that both male and female sex steroids play in mediating or protecting
against cardiovascular disease (CVD) and hypertension are controversial. For
example, whereas animal studies have strongly implicated androgens as being ... Cited by 67 - Related articles - All 8 versions
S Störk, C von Schacky, P Angerer - Atherosclerosis, 2002 - Elsevier Background: Intervention trials in postmenopausal women with coronary artery
disease have failed to demonstrate beneficial effects of hormone replacement
therapy (HRT) on the course of disease, potentially due to pro-inflammatory ... Cited by 60 - Related articles - All 9 versions
T De Jager, T Pelzer, S Mueller-Botz, A Imam … - Journal of Biological Chemistry, 2001 - ASBMB We have previously shown that the myocardium is a target tissue for estrogen.
Here, we have identified rapid non-nuclear estrogen effects on the expression of
the early growth response gene-1 (Egr-1) in cardiomyocytes. Egr-1 mRNA and ... Cited by 51 - Related articles - BL Direct - All 4 versions
- ►oxfordjournals.org [PDF] J Balasch - Human reproduction update, 2003 - ESHRE Although the process of bone remodelling or its control has not yet been fully
elucidated there is, at present, sufŽ- cient information available to conclude
that ovarian steroids (estrogens, androgens, progesterone) play an ... Cited by 45 - Related articles - BL Direct - All 6 versions
